> top > docs > PMC:7556165 > spans > 59356-59760 > annotations

PMC:7556165 / 59356-59760 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T348 240-248 Species denotes COVID-19 NCBItxid:2697049
T349 358-366 Species denotes COVID-19 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T360 0-404 Sentence denotes A definite conclusion would require specific prospective clinical trials, which are still running: https://clinicaltrials.gov/ct2/show/NCT04312009 is a multi-centered double blind trial with the aim to test the role of ARB in patients with COVID-19 and https://clinicaltrials.gov/ct2/show/NCT04331574 is another trial evaluating the outcome of patients with COVID-19 in therapy with either ACEI and ARBS.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
1630 226-234 Species denotes patients Tax:9606
1631 344-352 Species denotes patients Tax:9606
1632 240-248 Disease denotes COVID-19 MESH:C000657245
1633 358-366 Disease denotes COVID-19 MESH:C000657245

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T341 219-222 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T342 240-248 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T343 358-366 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1630 226-234 Species denotes patients Tax:9606
1631 344-352 Species denotes patients Tax:9606
1632 240-248 Disease denotes COVID-19 MESH:C000657245
1633 358-366 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T360 0-404 Sentence denotes A definite conclusion would require specific prospective clinical trials, which are still running: https://clinicaltrials.gov/ct2/show/NCT04312009 is a multi-centered double blind trial with the aim to test the role of ARB in patients with COVID-19 and https://clinicaltrials.gov/ct2/show/NCT04331574 is another trial evaluating the outcome of patients with COVID-19 in therapy with either ACEI and ARBS.